These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7585629)

  • 21. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
    Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
    Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
    Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
    Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
    Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.
    Giannini G; Ambrosini MI; Di Marcotullio L; Cerignoli F; Zani M; MacKay AR; Screpanti I; Frati L; Gulino A
    Mol Carcinog; 2003 Dec; 38(4):188-200. PubMed ID: 14639658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.
    Luwor RB; Johns TG; Murone C; Huang HJ; Cavenee WK; Ritter G; Old LJ; Burgess AW; Scott AM
    Cancer Res; 2001 Jul; 61(14):5355-61. PubMed ID: 11454674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of a novel human brain tumor-associated gene BR-3.
    Weil KC; Berge MS; Sehgal A
    Anticancer Res; 2002; 22(3):1467-74. PubMed ID: 12168825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro.
    Cole GW; Alleva AM; Reddy RM; Maxhimer JB; Zuo J; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1010-7. PubMed ID: 15867774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients.
    Niewiadomska H; Mirowski M; Stempień M; Błoński JZ; Czyz W; Switalska J; Matyga E; Hanausek M; Wierzbicki R
    Neoplasma; 2000; 47(1):8-14. PubMed ID: 10870681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered gene expression in drug-resistant human breast cancer cells.
    Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Cora EM; Buenafe MC; Liu D; Rademaker A; Fishman DA; Podratz KC; Reiter JL; Maihle NJ
    Cancer Treat Res; 2009; 149():189-202. PubMed ID: 19763437
    [No Abstract]   [Full Text] [Related]  

  • 32. A new antibody recognizing the vIII mutation of human epidermal growth factor receptor.
    Ohman L; Gedda L; Hesselager G; Larsson R; Nister M; Stigbrand T; Wester K; Carlsson J
    Tumour Biol; 2002; 23(2):61-9. PubMed ID: 12065843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation patterns of epidermal growth factor-receptor signaling in glioblastoma multiforme: in regard to Chakravarti et al. (Int J Radiat Oncol Biol Phys 2005;62:318-327).
    Altundag K; Altundag O; Gunduz E; Boruban C
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1253; author reply 1253. PubMed ID: 15990031
    [No Abstract]   [Full Text] [Related]  

  • 34. . . . and secreted tumour suppressors.
    Bradley A; Sharan SK
    Nat Genet; 1996 Jul; 13(3):268-9; author reply 269-72. PubMed ID: 8673123
    [No Abstract]   [Full Text] [Related]  

  • 35. Location of BRCA1 in human breast and ovarian cancer cells.
    Scully R; Ganesan S; Brown M; De Caprio JA; Cannistra SA; Feunteun J; Schnitt S; Livingston DM
    Science; 1996 Apr; 272(5258):123-6. PubMed ID: 8600523
    [No Abstract]   [Full Text] [Related]  

  • 36. Hydroxyapatite assay to measure epidermal growth factor receptor in human primary breast tumors.
    Benraad TJ; Foekens JA
    Ann Clin Biochem; 1990 May; 27 ( Pt 3)():272-3. PubMed ID: 2382963
    [No Abstract]   [Full Text] [Related]  

  • 37. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.
    Wikstrand CJ; Hale LP; Batra SK; Hill ML; Humphrey PA; Kurpad SN; McLendon RE; Moscatello D; Pegram CN; Reist CJ
    Cancer Res; 1995 Jul; 55(14):3140-8. PubMed ID: 7606735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor-related peptides and their receptors in human malignancies.
    Salomon DS; Brandt R; Ciardiello F; Normanno N
    Crit Rev Oncol Hematol; 1995 Jul; 19(3):183-232. PubMed ID: 7612182
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro evidence for the potential of EGFR inhibitors to decrease the TGF-β1-induced dispersal of circulating tumour cell clusters mediated by EGFR overexpression.
    Hapeman JD; Galwa R; Carneiro CS; Nedelcu AM
    Sci Rep; 2024 Aug; 14(1):19980. PubMed ID: 39198539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer.
    Wang Y; Shu H; Qu Y; Jin X; Liu J; Peng W; Wang L; Hao M; Xia M; Zhao Z; Dong K; Di Y; Tian M; Hao F; Xia C; Zhang W; Ba X; Feng Y; Wei M
    EMBO J; 2024 Jun; 43(12):2368-2396. PubMed ID: 38750259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.